Document:

Exhibit 4.3

  

  

  Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

  

  

  The following is brief description of the securities of Gardner Denver Holdings, Inc. (the “Company” “we,” “us” and “our”) registered pursuant to Section 12 of the
    Securities Exchange Act of 1934, as amended (the “Exchange Act”).  The following description of the Company’s common stock, par value $0.01 per share, is subject in all respects to the General Corporate Law of the State of Delaware (the “DGCL”) and to
    the full text of the Company’s second amended and restated certificate of incorporation (the “charter”)and the Company’s amended and restated bylaws (the “bylaws”).

  

  

  General

  

  

  Pursuant to our charter, our authorized capital stock consists of:

  

  

  
    
      	

            	•	
              1,000,000,000 shares of common stock, par value $0.01 per share; and

            

    

  

  

  

  
    
      	

            	•	
              100,000,000 shares of preferred stock, par value $0.01 per share.

            

    

  

  

  

  Common Stock

  

  

  Voting Rights

  

  

  Holders of our common stock are entitled to one vote for each share held of record on all matters to which stockholders are entitled to vote generally, including the
    election or removal of directors.  The holders of our common stock do not have cumulative voting rights in the election of directors.  The holders of our common stock are not entitled to vote on any amendment to our charter that relates solely to the
    terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon.  The number of authorized shares of
    preferred stock or common stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority in voting power of the stock of the Company entitled to vote thereon.

  

  

  Dividends

  

  

  The DGCL permits a corporation to declare and pay dividends out of “surplus” or, if there is no “surplus,” out of its net profits for the fiscal year in which the dividend
    is declared and/or the preceding fiscal year. “Surplus” is defined as the excess of the net assets of the corporation over the amount determined to be the capital of the corporation by the board of directors. The capital of the corporation is typically
    calculated to be (and cannot be less than) the aggregate par value of all issued shares of capital stock. Net assets equals the fair value of the total assets minus total liabilities. The DGCL also provides that dividends may not be paid out of net
    profits if, after the payment of the dividend, capital is less than the capital represented by the outstanding stock of all classes having a preference upon the distribution of assets.

  

  

  Declaration and payment of any dividend is subject to the discretion of our board of directors. The time and amount of dividends is dependent upon our financial condition,
    operations, cash requirements and availability, debt repayment obligations, capital expenditure needs and restrictions in our debt instruments, industry trends, the provisions of Delaware law affecting the payment of dividends to stockholders and any
    other factors our board of directors may consider relevant.

  

  

  
    

    
      

    

  

  Liquidation Rights

  

  

  Upon the Company’s liquidation, dissolution or winding up and after payment in full of all amounts required to be paid to creditors and to the holders of preferred stock
    having liquidation preferences, if any, the holders of our common stock are entitled to receive pro rata the Company’s remaining assets available for distribution.

  

  

  Preemptive and Other Rights

  

  

  Holders of our common stock do not have preemptive, subscription, redemption or conversion rights. The common stock is not subject to further calls or assessment by the
    Company. There is no redemption or sinking fund provisions applicable to the common stock.

  

  

  Preferred Stock

  

  

  Our charter authorizes our board of directors to establish one or more series of preferred stock (including convertible preferred stock). Unless required by law or by the
    New York Stock Exchange (“NYSE”), the authorized shares of preferred stock will be available for issuance without further action by common stockholders. Our board of directors may determine, with respect to any series of preferred stock, the powers
    (including voting powers), preferences and relative participations, optional or other special rights, and the qualifications, limitations or restrictions thereof, of that series, including, without limitation:

  

  

  
    
      	

            	•	
              the designation of the series;

            

    

  

  

  

  
    
      	

            	•	
              the number of shares of the series, which our board of directors may, except where otherwise provided in the preferred stock designation, increase (but not above the total number
                of authorized shares of the class) or decrease (but not below the number of shares then outstanding);

            

    

  

  

  

  
    
      	

            	•	
              whether dividends, if any, will be cumulative or non-cumulative and the dividend rate of the series;

            

    

  

  

  

  
    
      	

            	•	
              the dates at which dividends, if any, will be payable;

            

    

  

  

  

  
    
      	

            	•	
              the redemption rights and price or prices, if any, for shares of the series;

            

    

  

  

  

  
    
      	

            	•	
              the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series;

            

    

  

  

  

  
    
      	

            	•	
              the amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Company;

            

    

  

  

  

  
    
      	

            	•	
              whether the shares of the series will be convertible into shares of any other class or series, or any other security, of the Company or any other corporation, and, if so, the
                specification of the other class or series or other security, the conversion price or prices or rate or rates, any rate adjustments, the date or dates as of which the shares will be convertible and all other terms and conditions upon which
                the conversion may be made;

            

       

      

    

  

  
    
      	

            	•	
              restrictions on the issuance of shares of the same series or of any other class or series; and

            

    

  

  

  

  
    
      	

            	•	
              the voting rights, if any, of the holders of the series.

            

    

  

  

  

  
    

    
      

    

  

  We could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or
    a majority, of a stockholder might believe to be in its best interests or in which a stockholder might receive a premium for our common stock over the market price of the common stock. Additionally, the issuance of preferred stock may adversely affect
    the holders of our common stock by restricting dividends on the common stock, diluting the voting power of the common stock or subordinating the liquidation rights of the common stock. As a result of these or other factors, the issuance of preferred
    stock could have an adverse impact on the market price of our common stock.

  

  

  Anti-Takeover Effects of Our Charter and Bylaws and Certain Provisions of Delaware Law

  

  

  Our charter, bylaws and the DGCL, which are summarized in the following paragraphs, contain provisions that are intended to enhance the likelihood of continuity and
    stability in the composition of our board of directors. These provisions are intended to avoid costly takeover battles, reduce our vulnerability to a hostile change of control and enhance the ability of our board of directors to maximize stockholder
    value in connection with any unsolicited offer to acquire the Company. However, these provisions may have an anti-takeover effect and may delay, deter or prevent a merger or acquisition of the Company by means of a tender offer, a proxy contest or
    other takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the prevailing market price for the shares of common stock held by stockholders.

  

  

  Authorized but Unissued Capital Stock

  

  

  Delaware law does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of the NYSE, which would apply if and so long
    as our common stock remains listed on the NYSE, require stockholder approval of certain issuances equal to or exceeding 20% of the then outstanding voting power or then outstanding number of shares of common stock. These additional shares may be used
    for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions.

  

  

  Our board of directors may generally issue preferred shares on terms calculated to discourage, delay or prevent a change of control of the Company or the removal of our
    management. Moreover, our authorized but unissued shares of preferred stock are available for future issuances without stockholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise additional
    capital, acquisitions and employee benefit plans.

  

  

  One of the effects of the existence of unissued and unreserved common stock or preferred stock may be to enable our board of directors to issue shares to persons friendly
    to current management, which issuance could render more difficult or discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of our management and
    possibly deprive our stockholders of opportunities to sell their shares of common stock at prices higher than prevailing market prices.

  

  

  
    

    
      

    

  

  Classified Board of Directors

  

  

  Our charter provides that our board of directors be divided into three classes of directors, with the classes to be as nearly equal in number as possible, and with the
    directors serving three-year terms. As a result, approximately one-third of our board of directors are elected each year. The classification of directors has the effect of making it more difficult for stockholders to change the composition of our board
    of directors. Our charter and bylaws provide that, subject to any rights of holders of preferred stock to elect additional directors under specified circumstances, the number of directors are fixed from time to time exclusively pursuant to a resolution
    adopted by our board of directors.

  

  

  Business Combinations

  

  

  We have opted out of Section 203 of the DGCL; however, our charter contains similar provisions providing that the Company may not engage in certain “business combinations”
    with any “interested stockholder” for a three-year period following the time that the stockholder became an interested stockholder, unless:

  

  

  
    
      	

            	•	
              prior to such time, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

            

    

  

  

  

  
    
      	

            	•	
              upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock
                outstanding at the time the transaction commenced, excluding certain shares; or

            

    

  

  

  

  
    
      	

            	•	
              at or subsequent to that time, the business combination is approved by our board of directors and by the affirmative vote of holders of at least 662∕3% of the outstanding voting
                stock that is not owned by the interested stockholder.

            

    

  

  

  

  Generally, a “business combination” includes a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. Subject to
    certain exceptions, an “interested stockholder” is a person who, together with that person’s affiliates and associates, owns, or within the previous three years owned, 15% or more of our voting stock. For purposes of this section only, “voting stock”
    has the meaning given to it in Section 203 of the DGCL.

  

  

  Under certain circumstances, this provision makes it more difficult for a person who would be an “interested stockholder” to effect various business combinations with a
    corporation for a three-year period. This provision may encourage companies interested in acquiring the Company to negotiate in advance with our board of directors because the stockholder approval requirement would be avoided if our board of directors
    approves either the business combination or the transaction which results in the stockholder becoming an interested stockholder. These provisions also may have the effect of preventing changes in our board of directors and may make it more difficult to
    accomplish transactions which stockholders may otherwise deem to be in their best interests.

  

  

  Our charter provides that KKR Renaissance Aggregator L.P. (“KKR Renaissance Aggregator”) and its affiliates and any of their respective direct or indirect transferees and
    any group as to which such persons are a party do not constitute “interested stockholders” for purposes of this provision.

  

  

  
    

    
      

    

  

  Removal of Directors; Vacancies

  

  

  Under the DGCL, unless otherwise provided in our charter, directors serving on a classified board may be removed by the stockholders only for cause. Our charter provides
    that directors may be removed with or without cause upon the affirmative vote of a majority in voting power of all outstanding shares of stock entitled to vote thereon, voting together as a single class; provided, however, at any time when KKR
    Renaissance Aggregator and its affiliates beneficially own, in the aggregate, less than 40% in voting power of the stock of the Company entitled to vote generally in the election of directors, directors may only be removed for cause, and only by the
    affirmative vote of holders of at least 662∕3% in voting power of all the then-outstanding shares of stock of the Company entitled to vote thereon, voting together as a single class. In addition, our charter also provides that, subject to the rights
    granted to one or more series of preferred stock then outstanding or the rights granted under the Stockholders Agreement, dated as of May 17, 2017, between the Company and KKR Renaissance Aggregator (the “Stockholders Agreement”), any vacancies on our
    board of directors are filled only by the affirmative vote of a majority of the remaining directors, even if less than a quorum, by a sole remaining director or by the stockholders; provided, however, at any time when KKR Renaissance Aggregator and its
    affiliates beneficially own, in the aggregate, less than 40% in voting power of the stock of the Company entitled to vote generally in the election of directors, any newly created directorship on the board of directors that results from an increase in
    the number of directors and any vacancy occurring in the board of directors may only be filled by a majority of the directors then in office, although less than a quorum, or by a sole remaining director (and not by stockholders).

  

  

  No Cumulative Voting

  

  

  Under Delaware law, the right to vote cumulatively does not exist unless the certificate of incorporation specifically authorizes cumulative voting. Our charter does not
    authorize cumulative voting. Therefore, stockholders holding a majority in voting power of the shares of our stock entitled to vote generally in the election of directors are able to elect all of our directors.

  

  

  Special Stockholder Meetings

  

  

  Our charter provides that special meetings of our stockholders may be called at any time only by or at the direction of the board of directors or the chairman of the board
    of directors; provided, however, so long as KKR Renaissance Aggregator and its affiliates own, in the aggregate, less than 40% in voting power of the stock of the Company entitled to vote generally in the election of directors, special meetings of our
    stockholders shall also be called by the board of directors or the chairman of the board of directors at the request of KKR Renaissance Aggregator and its affiliates. Our bylaws prohibit the conduct of any business at a special meeting other than as
    specified in the notice for such meeting. These provisions may have the effect of deferring, delaying or discouraging hostile takeovers, or changes in control or management of the Company.

  

  

  Requirements for Advance Notification of Director Nominations and Stockholder Proposals

  

  

  Our bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations
    made by or at the direction of our board of directors or a committee of the board of directors. In order for any matter to be “properly brought” before a meeting, a stockholder will have to comply with advance notice requirements and provide the
    Company with certain information. Generally, to be timely, a stockholder’s notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the immediately preceding annual
    meeting of stockholders. Our bylaws also specify requirements as to the form and content of a stockholder’s notice. Our bylaws allow the chairman of the meeting at a meeting of the stockholders to adopt rules and regulations for the conduct of meetings
    which may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not followed. These provisions do not apply to KKR Renaissance Aggregator and its affiliates so long as the Stockholders Agreement
    remains in effect. These provisions may also defer, delay or discourage a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to influence or obtain control of the Company.

  

  

  
    

    
      

    

  

  Stockholder Action by Written Consent

  

  

  Pursuant to Section 228 of the DGCL, any action required to be taken at any annual or special meeting of the stockholders may be taken without a meeting, without prior
    notice and without a vote if a consent or consents in writing, setting forth the action so taken, is signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at
    a meeting at which all shares of our common stock entitled to vote thereon were present and voted, unless our charter provides otherwise. Our charter precludes stockholder action by written consent at any time when KKR Renaissance Aggregator and its
    affiliates beneficially own, in the aggregate, less than 40% in voting power of the stock of the Company entitled to vote generally in the election of directors; provided, that any action required or permitted to be taken by the holders of preferred
    stock, voting separately as a series or separately as a class with one or more other such series, may be taken by written consent to the extent provided by the applicable certificate of designation relating to such series.

  

  

  Supermajority Provisions

  

  

  Our charter and bylaws provide that the board of directors is expressly authorized to make, alter, amend, change, add to, rescind or repeal, in whole or in part, our
    bylaws without a stockholder vote in any matter not inconsistent with the laws of the State of Delaware or our charter. For as long as KKR Renaissance Aggregator and its affiliates beneficially own, in the aggregate, at least 40% in voting power of the
    stock of the Company entitled to vote generally in the election of directors, any amendment, alteration, rescission or repeal of our bylaws by our stockholders requires the affirmative vote of a majority in voting power of the outstanding shares of our
    common stock present in person or represented by proxy and entitled to vote on such amendment, alteration, rescission or repeal. At any time when KKR Renaissance Aggregator and its affiliates beneficially own, in the aggregate, less than 40% in voting
    power of the stock of the Company entitled to vote generally in the election of directors, any amendment, alteration, rescission or repeal of our bylaws by our stockholders requires the affirmative vote of the holders of at least 662∕3% in voting power
    of all the then-outstanding shares of stock of the Company entitled to vote thereon, voting together as a single class.

  

  

  The DGCL provides generally that the affirmative vote of a majority of the outstanding shares entitled to vote thereon, voting together as a single class, is required to
    amend a corporation’s certificate of incorporation, unless the certificate of incorporation requires a greater percentage.

  

  

  Our charter provides that at any time when KKR Renaissance Aggregator and its affiliates beneficially own, in the aggregate, less than 40% in voting power of the stock of
    the Company entitled to vote generally in the election of directors, the following provisions in our charter may be amended, altered, repealed or rescinded only by the affirmative vote of the holders of at least 662∕3 in voting power of all the
    then-outstanding shares of stock of the Company entitled to vote thereon, voting together as a single class:

  

  

  
    
      	

            	•	
              the provision requiring a 662∕3% supermajority vote for stockholders to amend our bylaws;

            

    

  

  

  

  
    
      	

            	•	
              the provisions providing for a classified board of directors (the election and term of our directors);

            

    

  

  

  

  
    
      	

            	•	
              the provisions regarding resignation and removal of directors;

            

    

  

  

  

  
    
      	

            	•	
              the provisions regarding competition and corporate opportunities;

            

    

  

  

  

  
    

    
      

    

  

  
    
      	

            	•	
              the provisions regarding entering into business combinations with interested stockholders;

            

    

  

  

  

  
    
      	

            	•	
              the provisions regarding stockholder action by written consent;

            

    

  

  

  

  
    
      	

            	•	
              the provisions regarding calling special meetings of stockholders;

            

    

  

  

  

  
    
      	

            	•	
              the provisions regarding filling vacancies on our board of directors and newly created directorships;

            

    

  

  

  

  
    
      	

            	•	
              the provisions eliminating monetary damages for breaches of fiduciary duty by a director; and

            

    

  

  

  

  
    
      	

            	•	
              the amendment provision requiring that the above provisions be amended only with a 662∕3% supermajority vote.

            

    

  

  

  

  The combination of the classification of our board of directors, the lack of cumulative voting and the supermajority voting requirements make it more difficult for our
    existing stockholders to replace our board of directors as well as for another party to obtain control of the Company by replacing our board of directors. Because our board of directors has the power to retain and discharge our officers, these
    provisions could also make it more difficult for existing stockholders or another party to effect a change in management.

  

  

  These provisions may have the effect of deterring hostile takeovers, delaying, or preventing changes in control of our management or the Company, such as a merger,
    reorganization or tender offer. These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage certain types of transactions that may involve an actual or
    threatened acquisition of the Company. These provisions are designed to reduce our vulnerability to an unsolicited acquisition proposal. The provisions are also intended to discourage certain tactics that may be used in proxy fights. However, such
    provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they also may inhibit fluctuations in the market price of our shares that could result from actual or rumored takeover attempts.
    Such provisions may also have the effect of preventing changes in management.

  

  

  Dissenters’ Rights of Appraisal and Payment

  

  

  Under the DGCL, with certain exceptions, our stockholders have appraisal rights in connection with a merger or consolidation of the Company. Pursuant to the DGCL,
    stockholders who properly request and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of Chancery. Our stockholders
    will not be entitled to exercise appraisal or dissenter’s rights under the DGCL in connection with the merger.

  

  

  Stockholders’ Derivative Actions

  

  

  Under the DGCL, any of our stockholders may bring an action in our name to procure a judgment in our favor, also known as a derivative action, provided that the
    stockholder bringing the action is a holder of our shares at the time of the transaction to which the action relates or such stockholder’s stock thereafter devolved by operation of law.

  

  

  
    

    
      

    

  

  Exclusive Forum

  

  

  Our charter provides that unless the Company consents to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent
    permitted by law, be the sole and exclusive forum for any (i) derivative action or proceeding brought on behalf of the Company, (ii) action asserting a claim of breach of a fiduciary duty owed by any director or officer of the Company to the Company or
    its stockholders, creditors or other constituents, (iii) action asserting a claim against the Company or any director or officer of the Company arising pursuant to any provision of the DGCL or our charter or bylaws or (iv) action asserting a claim
    against the Company or any director or officer of the Company governed by the internal affairs doctrine; provided, that, if and only if the Court of Chancery of the State of Delaware dismisses any such action for lack of subject matter jurisdiction,
    such action may be brought in another state court sitting in the State of Delaware. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Company shall be deemed to have notice of and consented to the
    forum provisions in our charter. The exclusive forum provision may apply to any of the foregoing types of actions; however, the Court of Chancery of the State of Delaware is not the sole and exclusive forum for actions brought under the federal
    securities laws. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Further, the enforceability of similar
    forum provisions in other companies’ certificates of incorporation has been challenged in legal proceedings, and it is possible that a court could find these types of provisions to be unenforceable. The combined company’s exclusive forum provision will
    not relieve it of its duties to comply with the federal securities laws and the rules and regulations thereunder, and its stockholders will not be deemed to have waived its compliance with these laws, rules and regulations.

  

  

  Conflicts of Interest

  

  

  Delaware law permits corporations to adopt provisions renouncing any interest or expectancy in certain opportunities that are presented to the corporation or its officers,
    directors or stockholders. Our charter, to the maximum extent permitted from time to time by Delaware law, renounces any interest or expectancy that the Company has in, or right to be offered an opportunity to participate in, specified business
    opportunities that are from time to time presented to our officers, directors or stockholders or their respective affiliates, other than those officers, directors, stockholders or affiliates who are the Company’s or its subsidiaries’ employees. Our
    charter provides that, to the fullest extent permitted by law, each of KKR Renaissance Aggregator or any of its affiliates or any director who is not employed by the Company (including any non-employee director who serves as one of the Company’s
    officers in both his director and officer capacities) or his or her affiliates has no duty to refrain from (i) engaging in a corporate opportunity in the same or similar lines of business in which the Company or its affiliates now engage or propose to
    engage or (ii) otherwise competing with the Company or its affiliates. In addition, to the fullest extent permitted by law, in the event that KKR Renaissance Aggregator or any of its affiliates or any non-employee director acquires knowledge of a
    potential transaction or other business opportunity which may be a corporate opportunity for itself or himself or its or his affiliates or for the Company or its affiliates, such person will have no duty to communicate or offer such transaction or
    business opportunity to the Company or any of its affiliates and they may take any such opportunity for themselves or offer it to another person or entity. Our charter does not renounce our interest in any business opportunity that is expressly offered
    to a non-employee director solely in his or her capacity as a director or officer of the Company. To the fullest extent permitted by law, no business opportunity will be deemed to be a potential corporate opportunity for the Company unless it would be
    permitted to undertake the opportunity under its second amended and restated certificate of incorporation, it has sufficient financial resources to undertake the opportunity and the opportunity would be in line with its business.

  

  

  
    

    
      

    

  

  Limitations on Liability and Indemnification of Officers and Directors

  

  

  The DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and their stockholders for monetary damages for breaches of
    directors’ fiduciary duties, subject to certain exceptions. Our charter includes a provision that eliminates the personal liability of directors for monetary damages for any breach of fiduciary duty as a director, except to the extent such exemption
    from liability or limitation thereof is not permitted under the DGCL. The effect of these provisions is to eliminate the rights of the Company and our stockholders, through stockholders’ derivative suits on the Company’s behalf, to recover monetary
    damages from a director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior. However, exculpation does not apply to any director if the director has acted in bad faith, knowingly or intentionally
    violated the law, authorized illegal dividends, repurchases or redemptions or derived an improper benefit from his or her actions as a director.

  

  

  Our bylaws provide that it must generally indemnify, and advance expenses to, its directors and officers to the fullest extent authorized by the DGCL. We are also
    expressly authorized to carry directors’ and officers’ liability insurance providing indemnification for our directors, officers and certain employees for some liabilities. the Company believes that these indemnification and advancement provisions and
    insurance are useful to attract and retain qualified directors and executive officers.

  

  

  The limitation of liability, indemnification and advancement provisions in our Charter and bylaws may discourage stockholders from bringing a lawsuit against directors for
    breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit the Company and its
    stockholders.

  

  

  Transfer Agent and Registrar

  

  

  American Stock Transfer & Trust Company, LLC is the transfer agent and registrar for our common stock.Exhibit 10.42

  

  

  
    
      	
               

            

       

      

      
        October 3, 2019

        

        

        Ms. Emily Weaver 

        11027 Westridge Dr. 

        Mukilteo, WA

        

        

        Dear Emily,

         

        This letter confirms my offer to you to join Gardner Denver Holdings, Inc. (the “Company”)

          as Senior Vice President and Chief Financial Officer, reporting directly to me as the Chief Executive Officer of the Company. Please note that the Company intends to change its name to Ingersoll-Rand after the closing of the proposed merger
          between the Company and the industrial segment of Ingersoll-Rand plc (the “Merger”).

         

        This offer is contingent upon your successful completion of a pre-employment drug screening with acceptable results, and proof of your right to work in the United
          States on your first day of employment.

         

        The terms of this offer include the following:

         

        
          
            	

                  	1.	
                    Salary: Your annual base salary will be $575,000 paid on a semi-monthly basis. You  will be eligible for your first salary review during our annual salary planning process in April 2021.

                  

          

        

         

        
          
            	

                  	2.	
                    Signing Bonus: You will receive a one-time payment in the amount of  $500,000, payable within ten (10) business days following your Date of Hire (as defined below). Should you voluntarily terminate your employment with
                      the Company without Good Reason (as defined below) or be involuntarily terminated by the Company for Cause (as defined below) within 24 months from the Date of Hire (as defined below), you will be required to repay to repay this
                      amount in full.

                  

          

        

         

        
          
            	

                  	3.	
                    Management Incentive Plan: Beginning in 2020 and for each subsequent fiscal year, you will be eligible to earn an annual cash incentive award under the Company’s Management Incentive Plan, subject to the terms and
                      conditions of such plan as in effect from time to time (the “MIP”). Your target annual incentive opportunity under the MIP for each fiscal year will be 85%
                      of your annual base salary as in effect at the end of the given fiscal year (the “Target Bonus”). Your actual annual cash incentive award may be greater or
                      lesser than your target annual incentive opportunity, depending on the Company’s performance against its goals and otherwise as may be provided under the MIP.

                  

             

            

          

        

        
          
            

          
            	
                     

                  

          

        

        The specific performance objectives and measures for your annual incentive opportunity will be defined for each fiscal year,
          and your annual incentive award will be calculated, approved, and paid after financial results for the given fiscal year have been finalized, all in accordance with the terms of the MIP.

         

        Your annual bonus in respect of the 2019 fiscal year will be equal to the Target Bonus, prorated based on the period of time
          during which you are employed by the Company in 2019.

         

        
          
            	

                  	4.	
                    Long Term Incentive Plan: Beginning in 2020, you will be eligible to participate in the Company’s long term incentive plan. Your target annual equity grant opportunity under the plan will be equal to $1,650,000, with your
                      actual award being more or less than your target opportunity depending on your individual performance and the Company’s performance against its goals and otherwise as may be provided under the plan. The annual equity grant under the
                      Company’s long term incentive plan currently consists of 50% stock option (with a ten year term) and 50% restricted stock (with both awards vesting in equal tranches over the four year period after the grant date), which is subject to
                      change if changes are made to the overall plan or executive grants generally by the Company’s Compensation Committee. In the past, the grant date for annual long term incentive awards has been in the first quarter of each year. In
                      addition to the foregoing, you will receive an equity grant as close to the Date of Hire as possible and in no case later than December 31, 2019, that will be equal to $2,500,000 in grant date value (the “Initial Equity Grant”). This
                      grant will be comprised of 75% restricted stock ($1,875,000) and 25% stock option ($625,000). The stock option will have a ten-year term and a per share exercise price equal to the fair market value of a share of the Company’s common
                      stock on the date of grant, and the number of shares subject to the option grant will be determined using the Black-Scholes model. Each of the restricted stock and option grants will vest over four years with no vesting on the first
                      anniversary of the grant date, and then vesting in equal thirds on the second, third and fourth anniversaries of the grant date, and are otherwise subject to the terms and conditions of the long term incentive plan and those contained
                      in the standard executive grant documents. The terms of the Initial Equity Grant will provide for full acceleration of vesting if within two years of a change of control, the Company terminates your employment without Cause or you
                      terminate your employment for Good Reason.

                  

          

        

        

        

        
          	

                	5.	
                  Retirement Plans: You will be eligible to participate in the Company’s retirement savings plans, subject to the terms of such
                    plans as may be in effect from time to time.

                

        

         

        

        
          
            	

                  	6.	
                    Health and Welfare Benefits Coverage: As of your Date of Hire, you will be eligible for health and welfare benefits coverage, including medical, dental, and life insurance  and disability, along with a
                      comprehensive wellness program for your health and well- being. The Company’s benefits plan coverage year begins on each April 1st and ends on the subsequent March
                      31st.

                  

             

            

          

        

        
          
            

          
            	
                     

                  

          

        

        
          
            	

                  	7.	
                    Work Location; Relocation: Initially, your work location will be Milwaukee, Wisconsin, and you may commute to Milwaukee from your current residence. Your airfare, hotel (or corporate apartment), meals, and other
                      commuting costs between Seattle and Milwaukee will not be treated as relocation benefits and will be reimbursed subject to the Company’s travel policies. Following the closing of the Merger, or sooner as we may agree, your work
                      location will be Davidson, North Carolina. You will be eligible for the benefits under the Company’s executive relocation program with respect to the move of your family to Davidson. You are required to complete your and your family’s
                      relocation to Davidson by no later than June 1, 2020 (or as otherwise agreed to by the Company), unless the Merger is delayed or terminated (in which case you will relocate to  Milwaukee, WI by a date reasonably agreed to by you and
                      the Company).

                  

          

        

         

        
          
            	

                  	8.	
                    Vacation: You will receive four weeks of paid vacation per year.

                  

          

        

        

        

        
          
            	

                  	9.	
                    Date of Hire: Your employment with the Company will commence on December 1, 2019, or such earlier date as  you and the Company may agree (your “Date of
                          Hire”).  You hereby agree to resign from your current employment effective as of a date to be mutually agreed with the Company, but in no event later than October 9, 2019.

                  

          

        

         

        
          
            	

                  	10.	
                    Severance Arrangements: If the Company withdraws this offer before your Date of  Hire without Cause, terminates your employment without Cause, or you resign for Good Reason, the Company will:

                  

          

        

         

        
          
            	

                  	a.	
                    pay you an amount equal to your then current annual base salary, which amount shall be payable in 12 substantially equal monthly installments following the termination date
                      with the first installment occurring in the calendar month after the month of the termination date (and pay you the Section 2 $500,000 signing bonus and Section 13 legal fees, if not previously paid to you); and

                  

          

        

         

        
          
            	

                  	b.	
                    so long as you timely elect to continue to participate in the Company’s group health plan under COBRA, provide you with continued coverage under such group health plan on the
                      same basis as actively employed employees of the Company for the 12 month period commencing with the first day of the calendar month following the date your employment terminates (or, if earlier, through the date you become employed
                      by another employer and are eligible for comparable group health plan coverage at such employer).

                  

          

        

        

        

        “Cause” for purposes of this offer means your (a) willful neglect in the performance of the your duties for the Company or
          its affiliates or willful or repeated failure or refusal to perform such duties; (b) engagement in conduct in connection with your employment or service with the Company or its affiliates, which results in, or could reasonably be expected to
          result in, material harm to the business or reputation of the Company or any of its affiliates; (c) conviction of, or plea of guilty or no contest to, (i) any felony; or (ii) any other crime that results in, or could reasonably be expected to
          result in, material harm to the business or reputation of the Company or any of its affiliates; (d) engaging in any act of moral turpitude, illegality or harassment, whether or not such act was committed in connection with your services to the
          Company or any of its affiliates; (f) material violation of the Company’s Code of Conduct or any other written policies of the Company or its affiliates, including, but not limited to, those relating to sexual  harassment or the disclosure or
          misuse of confidential information, or those set forth in the manuals or statements of policy of the Company or any of its affiliates; (g) fraud or misappropriation, embezzlement or misuse of funds or property belonging to the Company or any of
          its affiliates; (h) act of personal dishonesty that involves personal profit in connection with the your employment or service to the Company or any of its affiliates; or (i) material misrepresentation of any information provided by you to the
          Company during your pre-employment discussions and/or negotiations with the Company.

         

        

        
          
            

          
            	
                     

                  

          

        

        ‘‘Good Reason’’ for purposes of this offer letter means any of the following actions if taken without your prior written
          consent: (1) a material adverse change in your position causing it to be of materially less stature, responsibility, or authority or the assignment to you of any material duties inconsistent with the customary duties of your position (provided
          that if the Company or its successor entity ceases to be a publicly traded entity or if the Merger is delayed or does not close, any such fact shall not by itself constitute a change in your existing position); (2) the relocation of the offices
          at which you are principally employed to a location which is more than 50 miles from the offices at which you are principally employed immediately prior to such relocation (not including your anticipated move to Davidson, North Carolina or
          Milwaukee, Wisconsin); or (3) a reduction in your base salary or the Target Bonus percentage or amount you are eligible to earn under the MIP; provided, however, that nothing herein shall be construed to guarantee your MIP award payable for any
          fiscal year if the applicable performance targets are not met; and provided, further, that it shall not constitute Good Reason if the Company makes an appropriate pro rata adjustment to the applicable amount payable and targets under the MIP in
          the event of a change in the fiscal year. Unless you provide written notification of an event described in any of clauses (1)-(3) above within ninety (90) days after you know or have reason to know of the occurrence of  any such event, you shall
          be deemed to have consented thereto and such event shall no longer constitute Good Reason for purposes of this letter. If you provides such written notification to the Company, the Company shall have ten (10) Business Days from the date of
          receipt of such notice to effect a cure of the event described therein and, upon cure thereof by the Company to your reasonable satisfaction, such event shall no longer constitute Good Reason for purposes of this letter. A resignation for Good
          Reason shall be considered to be and treated for all purposes as a Termination without Cause under this letter. 

         

        Receipt of the above severance payments and benefits is contingent on your execution (without revocation) of a waiver and
          release agreement in a form customarily used by the Company by not later than 60 days following the date on which your employment terminates and is subject to your continued compliance with any applicable restrictive covenants contained in any
          agreement entered into with the Company or any of its affiliates. No severance payments will commence until the waiver and release agreement becomes effective (with the first payment including all payments that would otherwise have been made if
          this sentence did not apply) and, if the aforementioned 60-day period spans two calendar years and if required to comply with Internal Revenue Code Section 409A, such first payment will be made in the second calendar year. For purposes of
          Internal Revenue Code Section 409A, each installment of the severance payments shall be deemed to be a separate payment.

         

        

        
          
            

          
            	
                     

                  

          

        

        
          
            	

                  	11.	
                    Restrictive Covenants: By signing and accepting this offer of employment, you represent and warrant that: (a) you are not subject to any pre-existing restrictive covenant or other contractual or legal obligation with
                      any person, company or business enterprise restricting your ability to work for the Company that you have not disclosed to the Company; (b) you have not and shall not bring onto Company premises, or use in the course of your
                      employment with the Company, any confidential or proprietary information of another person, company or business enterprise to whom you previously provided services; and (c) you are not relying on any representations, promises or
                      agreements not expressly contained in this offer letter or any legal advice except as provided by your own counsel. You further agree to keep this offer, its terms and any confidential or proprietary information of the Company that
                      you may acquire during the process of receiving and negotiating this offer, confidential.

                  

          

        

         

        
          
            	

                  	12.	
                    
                      Indemnity: You have provided to the Company a complete and correct copy of an Agreement Regarding Competition and Protection of Proprietary Information that you entered into with your immediate
                        prior employer, Fortive Corporation (the “Prior Employer,” and the foregoing agreement, the “Prior

                            Employer Restrictive Covenant Agreement”). You hereby represent to the Company that you have not breached any of your lawful obligations to the Prior Employer under the Prior Employer Restrictive Covenant Agreement,
                        and further agree to continue to comply with your lawful obligations under the Prior Employer Restrictive Covenant Agreement. Both you and the Company acknowledge and agree that you and it respectively reviewed your post-
                        termination obligations under the Prior Employer Restrictive Covenant Agreement and have separately concluded that your employment with the Company, both pre and post- Merger, does not violate Section 5 of the Prior Employer
                        Restrictive Covenant  Agreement (the “Prior Employer Non-Compete Covenant”) (and therefore under no circumstances will the Company deem your employment
                        with the Company to be a breach of any of your representations contained herein). The Company shall defend, indemnify and hold you harmless from, against and in connection with: (A) any Proceeding (as defined below); and (B) any
                        attorneys’ fees, expert and other fees, costs, fines, filing fees, penalties, travel expenses, liabilities, damages, settlements, judgments  or other expenses or amounts of any kind whatsoever in each case brought or alleged against
                        you or incurred or suffered by you as a result of any act or omission arising from, relating to, or occurring in connection with your pre-employment discussions with, negotiations with, or employment with the Company or its
                        Affiliates, which act or omission is or is alleged to be in violation of the Prior Employer Restrictive Covenant Agreement. A “Proceeding” includes but is not limited to any threatened or actual legal  or administrative action or
                        proceeding, whether civil or criminal, including any government or regulatory proceedings, arbitrations, lawsuits, mediations, settlement discussions and investigations in which you are or may be made, or are threatened to be made,
                        a party, witness or other participant.

                    

                  

          

        

        

        

        
          
            

          
            	
                     

                  

          

        

        The Company’s obligation to defend, indemnify and hold you harmless is subject to the following conditions: (a) you promptly
          notify the Company in writing of the existence or threat of any such Proceeding; (b) the Company shall have full control of the response to any Proceeding and the defense thereof, including any agreement relating to the settlement thereof; (c)
          you shall provide your full cooperation in connection with any such Proceeding (including appeals); and (d) you have not breached any of your representations contained herein. You may, at your own expense, participate in such defense and in any
          settlement discussions through separate counsel of your choice, on a monitoring, non-controlling basis. The Company will not be responsible for any settlement or compromise entered into by you without the Company’s consent. The foregoing duty to
          defend and indemnify you shall apply to the fullest extent permitted by applicable law. If, as a result of a Proceeding, you are enjoined or otherwise prohibited from working for a period of time for the Company in the position of Chief Financial
          Officer for the Company, the Company shall continue to pay your base salary and any annual bonus you would have earned if working (but no other payment or benefits otherwise described in this offer letter) for any such period of time; provided, that you have not breached any of your representations contained herein. The Company further agrees to maintain a commercially reasonable directors and officers
          liability insurance policy.

         

        
          
            	

                  	13.	
                    Legal Fees: The Company will reimburse you for the legal fees you incur in
                      connection with the negotiation of this offer letter, up to a maximum amount of $10,000. This amount shall be paid to you in all cases in 2019.

                  

          

        

         

        
          
            	

                  	14.	
                    Other Conditions: This offer of employment, and your continued employment hereunder, is further conditioned upon your signed agreement to, and ongoing  compliance with, any code of conduct, business ethics and restrictive
                      covenant agreements required to be signed by senior level employees of the Company.

                  

          

        

         

        
          
            	

                  	15.	
                    Miscellaneous: The Company shall be entitled to withhold from the payment of any compensation and provision of any benefit under this offer letter such amounts as may be required by applicable law, including without
                      limitation for purposes of the payment of payroll and income taxes. This offer letter and any dispute hereunder shall be interpreted and governed in accordance with the laws of the State of Delaware without reference to rules relating
                      to conflicts of law. This offer letter supersedes and replaces in its entirety any verbal or written agreements, promises or statements between the parties with respect to the subject matters herein.  In the event of a conflict
                      between the terms of this offer  and the terms of any other agreement or Company policy, the terms of this offer letter will prevail.

                  

             

            

          

        

        
          
            

          
            	
                     

                  

          

        

        
          Emily, I am very excited about the prospect of you accepting this offer and becoming part of our executive team. I am confident that together we can achieve our
            goal of growing the Company and creating significant value for all stakeholders.

          

          

           

          Sincerely,

          
            

            

            
              
                	
                        /s/ Vicente Reynal

                      	
                         

                      
	
                        Vicente Reynal

                      	
                         

                      

              

               

            

          

          

          Chief Executive Officer

           

          Cc: Andy Schiesl

           

          

          
            

          
            
              I have read and accept this offer of employment and agree to the terms and conditions

            

             

            

            ACCEPTED AND AGREED:

          

           

          

          
            	/s/ Emily Weaver

                  	
                     

                  
	Name

                  	
                     

                  
	 	 
	10/3/2019

                  	
                     

                  
	Date

                  	
                     

                  

          

           

          

          
            Offer of employment expires four (4) days from the date of this offer letter unless an extension is mutually agreed upon.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]